Navigation Links
Yongye International Announces First Quarter 2013 Financial Results
Date:5/10/2013

,508,738General and administrative expenses, including a reversal of

allowance for doubtful accounts of nil and US$6,334,832 for three

months ended March 31, 2013 and 2012, respectively4,069,972(2,209,471)Income from operations1,135,39721,910,181Other (expenses)/incomeInterest expenses(1,866,378)(1,004,169)Interest income165,75860,074Other (expenses)/income, net(64,336)32,054Change in fair value of derivative liabilities-59,398Total other income, net(1,764,956)(852,643)(Losses)/earnings before income tax expense(629,559)21,057,538Income tax (benefit)/expense(5,079)3,740,222Net (loss)/income(624,480)17,317,316Less: Net (loss)/income attributable to the noncontrolling 

interest(11,908)935,026Net (loss)/income attributable to Yongye International, Inc.

$

(612,572)$

16,382,290Net (loss)/income per share of common stock
Basic

$

(0.03)$

0.28
Diluted

$

(0.03)$

0.27Weighted average shares used in computation:
Basic 
50,669,88049,370,711
Diluted 
50,669,88049,460,252Net (loss)/income(624,480)17,317,316Other comprehensive incomeForeign currency translation adjustment, net of US$ nil

income taxes2,663,2362,341,251Comprehensive income2,038,75619,658,567Less: Comprehensive income attributable to the noncontrolling

interest114,0801,043,895Comprehensive income attributable to Yongye International, Inc.

$

1,924,676$

18,614,672YONGYE INTERNATIONAL, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWSFor the Three Months EndedMarch 31, 2013 March 31, 2012
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Yongye International to Report First Quarter 2013 Financial Results on May 10, 2013
2. Yongye International Announces Second Quarter 2012 Financial Results
3. Yongye International to Report Second Quarter 2012 Financial Results on August 9, 2012
4. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York
5. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
6. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
7. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
8. Danai Brooks Joins Dyadic International as Chief Operating Officer
9. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
10. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
11. GeneCell International Gives Back to the Community by Participating in Local Elementary School’s Career Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... Md. (PRWEB) February 27, 2015 ... Chromatography system (Nexera UC) can sequentially analyze up ... separation combined with high-sensitivity detection of targets by ... is designed to fulfill the measurement requirements of ... in food products, drug delivery and search for ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... CAMBRIDGE, Mass., Oct. 31 Idenix,Pharmaceuticals, Inc., (Nasdaq: ... results for the third quarter of 2007 on Tuesday, ... In conjunction with the issuance of the press release, ... ET on Tuesday, November,6, 2007 to discuss the company,s ...
... tech development, opportunities for business growth, COLUMBUS, ... Ohio,colleges and universities increased academic research expenditures in ... than ever into high,technology R&D sectors throughout the ... high tech research, development and,commercialization, especially in the ...
... SAN FRANCISCO, Oct. 31 Medivation, Inc.,(Nasdaq: MDVN ... chief,executive officer, will present at the Acumen BioFin Rodman ... at 11:15 a.m. Eastern,Time at the New York Palace ... Medivation and its clinical,development programs for Dimebon(TM) for Alzheimer,s ...
Cached Biology Technology:Ohio Academic Institutions Increase Research and Development Investments 2Ohio Academic Institutions Increase Research and Development Investments 3Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ... in general the State of Washington,s ... a new enrollment and central issuance system for driver,s licenses ... The project planning and development will start in January ...
(Date:1/22/2015)... Fla. , Jan. 13, 2015  Today, FreeWavz ... technology, launched its crowdfunding campaign on Fundable, ... the build of production capacity to meet customer ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Haven, Conn.Paleontologists have discovered a new species of dinosaur with ... skull, according to a paper published in the April issue ... species was a plant-eating dinosaur about as big as a ... said Nicholas Longrich of Yale University, lead author of the ...
... RIVERSIDE, Calif. Robert Luck , a professor of ... California Citrus Quality Council,s prestigious Albert G. Salter Memorial Award ... Luck is a leading expert in the research ... "This is a truly deserving award for Professor Luck ...
... The Marine Protected Areas Federal Advisory Committee will meet ... Charleston, S.C. The committee advises the Department of Commerce ... to the national system of MPAs. The ... includes integrating the national MPA system with the Coastal ...
Cached Biology News:New bony-skulled dinosaur species discovered in Texas 2UC Riverside entomologist recognized for research in citrus entomology 2
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
Request Info...
... The Cellject Uno Electroporator is ... for producing optimum efficiencies in bacterial ... simply selects one of two voltages ... or four mm cuvettes. On pressing ...
Request Info...
Biology Products: